Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Shands Jacksonville Medical Center
mi
from
Jacksonville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Shands Jacksonville Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Florida Hospital
mi
from
Orlando, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Saint Joseph's Research Institute
mi
from
Atlanta, GA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Saint Joseph's Research Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Northwestern Cardiovascular Institute
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Northwestern Cardiovascular Institute
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Rush University Medical Center
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Iowa Health Care
mi
from
Iowa City, IA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Iowa Health Care
mi
from
Iowa City, IA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Massachusetts General Hospital
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Caritas Saint Elizabeth's Medical Center
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Caritas Saint Elizabeth's Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Minneapolis Heart Institute
mi
from
Minneapolis, MN
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Weill-Cornell Medical College
mi
from
New York, NY
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
New York-Presbyterian Hospital
mi
from
New York, NY
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Lindner Clinical Trials Center
mi
from
Cincinnati, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Lindner Clinical Trials Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University Hospitals of Cleveland
mi
from
Cleveland, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Swedish Medical Center
mi
from
Seattle, WA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Wisconsin
mi
from
Madison, WI
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Heart Care Associates
mi
from
Milwaukee, WI
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Heart Care Associates
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
Status: Enrolling
Updated:  9/10/2010
Ridgeview Medical Center
mi
from
Waconia, MN
Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
Status: Enrolling
Updated: 9/10/2010
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
Mechanism of the Anti-remodeling Activity of the Over-the-counter Dietary Supplement, Pycnogenol, on Age-dependent Process of Cardiac Fibrosis in Aged Hypertensive Subjects With Echocardiographic Evidence of Grade I/II Diastolic Dysfunction
Status: Enrolling
Updated:  9/17/2010
The University of Arizona Sarver Heart Center
mi
from
Tucson, AZ
Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
Mechanism of the Anti-remodeling Activity of the Over-the-counter Dietary Supplement, Pycnogenol, on Age-dependent Process of Cardiac Fibrosis in Aged Hypertensive Subjects With Echocardiographic Evidence of Grade I/II Diastolic Dysfunction
Status: Enrolling
Updated: 9/17/2010
The University of Arizona Sarver Heart Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  9/20/2010
Albany Medical College
mi
from
Albany, NY
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 9/20/2010
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  9/20/2010
Image Care Latham
mi
from
Latham, NY
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 9/20/2010
Image Care Latham
mi
from
Latham, NY
Click here to add this to my saved trials
Washed Versus Standard Blood Cell Transfusions in Pediatric Open Heart Surgery
Standard vs. Washed Blood Cell Transfusions in Pediatric Cardiac Surgery: Impact on Post-operative Inflammation as Evidenced by the IL-6 to IL-10 Ratio.
Status: Enrolling
Updated:  9/30/2010
University of Rochester
mi
from
Rochester, NY
Washed Versus Standard Blood Cell Transfusions in Pediatric Open Heart Surgery
Standard vs. Washed Blood Cell Transfusions in Pediatric Cardiac Surgery: Impact on Post-operative Inflammation as Evidenced by the IL-6 to IL-10 Ratio.
Status: Enrolling
Updated: 9/30/2010
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Intravascular Optical Coherence Tomography Imaging to Determine the Length of Anti-Platelet Therapy After Drug Eluting Stent Placement
Frequency Domain Imaging to Determine Stent Strut Coverage and Duration of Anti-Platelet Treatment After Endeavor Stent Placement
Status: Enrolling
Updated:  10/11/2010
Emory University Hospital Midtown
mi
from
Atlanta, GA
Intravascular Optical Coherence Tomography Imaging to Determine the Length of Anti-Platelet Therapy After Drug Eluting Stent Placement
Frequency Domain Imaging to Determine Stent Strut Coverage and Duration of Anti-Platelet Treatment After Endeavor Stent Placement
Status: Enrolling
Updated: 10/11/2010
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated:  10/22/2010
San Francisco Center for Advanced Wound Care
mi
from
Daly City, CA
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated: 10/22/2010
San Francisco Center for Advanced Wound Care
mi
from
Daly City, CA
Click here to add this to my saved trials
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated:  10/22/2010
The SF Center For Advanced Wound Care At
mi
from
Daly City, CA
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated: 10/22/2010
The SF Center For Advanced Wound Care At
mi
from
Daly City, CA
Click here to add this to my saved trials
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Status: Enrolling
Updated:  11/3/2010
Northwestern University
mi
from
Chicago, IL
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Status: Enrolling
Updated: 11/3/2010
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Status: Enrolling
Updated:  11/3/2010
Northwestern University
mi
from
Chicago, IL
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Status: Enrolling
Updated: 11/3/2010
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease
Determinants of Cardiac Risk Factors Modification
Status: Enrolling
Updated:  11/4/2010
Joan and Sanford I. Weill Medical College
mi
from
New York, NY
Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease
Determinants of Cardiac Risk Factors Modification
Status: Enrolling
Updated: 11/4/2010
Joan and Sanford I. Weill Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Molecular Basis of Congenital Heart Defects
Molecular Basis of Congenital Heart Defects
Status: Enrolling
Updated:  11/5/2010
Taosheng Huang
mi
from
Orange, CA
Molecular Basis of Congenital Heart Defects
Molecular Basis of Congenital Heart Defects
Status: Enrolling
Updated: 11/5/2010
Taosheng Huang
mi
from
Orange, CA
Click here to add this to my saved trials
Botulinum Toxin in the Treatment of Raynaud's
Botulinum Toxin in the Treatment of Raynaud's
Status: Enrolling
Updated:  11/17/2010
Emroy University
mi
from
Atlanta, GA
Botulinum Toxin in the Treatment of Raynaud's
Botulinum Toxin in the Treatment of Raynaud's
Status: Enrolling
Updated: 11/17/2010
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Botulinum Toxin in the Treatment of Raynaud's
Botulinum Toxin in the Treatment of Raynaud's
Status: Enrolling
Updated:  11/17/2010
Emroy University
mi
from
Atlanta, GA
Botulinum Toxin in the Treatment of Raynaud's
Botulinum Toxin in the Treatment of Raynaud's
Status: Enrolling
Updated: 11/17/2010
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively
Status: Enrolling
Updated:  11/24/2010
Retina Consultants of Hawaii
mi
from
Aiea, HI
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively
Status: Enrolling
Updated: 11/24/2010
Retina Consultants of Hawaii
mi
from
Aiea, HI
Click here to add this to my saved trials
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively
Status: Enrolling
Updated:  11/24/2010
Retina Consultants of Hawaii, Inc
mi
from
Honolulu, HI
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively
Status: Enrolling
Updated: 11/24/2010
Retina Consultants of Hawaii, Inc
mi
from
Honolulu, HI
Click here to add this to my saved trials
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
A Prospective Randomized Trial of Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Mitral Operation
Status: Enrolling
Updated:  11/29/2010
University of Maryland School of Medicine
mi
from
Baltimore, MD
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
A Prospective Randomized Trial of Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Mitral Operation
Status: Enrolling
Updated: 11/29/2010
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
Status: Enrolling
Updated:  11/30/2010
Texas Children's Hospital
mi
from
Houston, TX
Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
Status: Enrolling
Updated: 11/30/2010
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
Phase 3 Study of Atorvastatin Effects on Carotid Atherosclerosis
Status: Enrolling
Updated:  12/2/2010
Baylor College of Medicine
mi
from
Houston, TX
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
Phase 3 Study of Atorvastatin Effects on Carotid Atherosclerosis
Status: Enrolling
Updated: 12/2/2010
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
Ranibizumab in Residual Diabetic Macular Edema Following Previous Intravitreal Bevacizumab Therapy
Status: Enrolling
Updated:  12/2/2010
New England Retina Associates
mi
from
Hamden, CT
Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
Ranibizumab in Residual Diabetic Macular Edema Following Previous Intravitreal Bevacizumab Therapy
Status: Enrolling
Updated: 12/2/2010
New England Retina Associates
mi
from
Hamden, CT
Click here to add this to my saved trials
Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
The Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Artery Plaques in Patients With Moderate Coronary Artery Disease
Status: Enrolling
Updated:  12/6/2010
Emory University Hospital
mi
from
Atlanta, GA
Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
The Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Artery Plaques in Patients With Moderate Coronary Artery Disease
Status: Enrolling
Updated: 12/6/2010
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Status: Enrolling
Updated:  12/15/2010
Johns Hopkins Hospital
mi
from
Baltimore, MD
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
Status: Enrolling
Updated: 12/15/2010
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest
Study of the Use of Mild Hypothermia in Out-of-hospital Cardiac Arrest Using a Rapid Infusion of 2 Liters of Cold Normal Saline
Status: Enrolling
Updated:  12/29/2010
Harborview Medical Center
mi
from
Seattle, WA
Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest
Study of the Use of Mild Hypothermia in Out-of-hospital Cardiac Arrest Using a Rapid Infusion of 2 Liters of Cold Normal Saline
Status: Enrolling
Updated: 12/29/2010
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated:  1/7/2011
The Mayo Clinic
mi
from
Rochester, MN
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated: 1/7/2011
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated:  1/7/2011
St. John's Mercy Medical Center
mi
from
St. Louis, MO
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated: 1/7/2011
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated:  1/7/2011
Rhode Island Hospital
mi
from
Providence, RI
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated: 1/7/2011
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated:  1/7/2011
MD Anderson
mi
from
Houston, TX
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated: 1/7/2011
MD Anderson
mi
from
Houston, TX
Click here to add this to my saved trials
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated:  1/7/2011
Blacktown Hospital
mi
from
Blacktown,
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Status: Enrolling
Updated: 1/7/2011
Blacktown Hospital
mi
from
Blacktown,
Click here to add this to my saved trials
Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry
Incidence, Predictors and Impact of Response Variability to Oral Dual Antiplatelet Therapy, as Measured by Point-of-care Platelet Aggregometry, Following Percutaneous Coronary Intervention
Status: Enrolling
Updated:  1/19/2011
University of Chicago
mi
from
Chicago, IL
Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry
Incidence, Predictors and Impact of Response Variability to Oral Dual Antiplatelet Therapy, as Measured by Point-of-care Platelet Aggregometry, Following Percutaneous Coronary Intervention
Status: Enrolling
Updated: 1/19/2011
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Mind-body Interventions in Cardiac Patients
Status: Enrolling
Updated:  1/20/2011
Massachusetts General Hospital
mi
from
Boston, MA
Mind-body Interventions in Cardiac Patients
Status: Enrolling
Updated: 1/20/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Status: Enrolling
Updated:  1/30/2011
University of California- Davis Medical Center
mi
from
Davis, CA
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Status: Enrolling
Updated: 1/30/2011
University of California- Davis Medical Center
mi
from
Davis, CA
Click here to add this to my saved trials
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Status: Enrolling
Updated:  1/30/2011
Stanford University Vascular Surgery
mi
from
Palo Alto, CA
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair
Status: Enrolling
Updated: 1/30/2011
Stanford University Vascular Surgery
mi
from
Palo Alto, CA
Click here to add this to my saved trials